AI Article Synopsis
- The number of global cancer patients is rising dramatically, with WHO predicting 15 million new cases in 2020 compared to 10 million in 2000.
- Researchers are making significant efforts to develop effective cancer treatments, including recent advances with PARP and PARG inhibitors.
- This review discusses how these inhibitors work and their current status in cancer treatment development.
Article Abstract
Today, the number of cancer patients throughout the world is increasing alarmingly and as per the World Health Organisation (WHO) data and statistics the prediction for the year 2020 will be 15 million new cases as compared to only 10 million cases in year 2000 leaving us dumbfounded. A lot of effort has been put in by researchers and scientists over decades to find drugs helpful in the treatment of cancers for the benefit of patients--the latest being the Poly ADP-ribose polymerase (PARP) and the Poly ADP-ribose glycohydrolase (PARG) inhibitors. This review highlights their mechanism of action under the rationale of their use and current development in the field of cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12253-010-9266-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!